CD14 and Parkinson disease: Recent studies have shown that CD38 on Plasma Blast-Plasma cells was associated with a lower risk of Parkinson’s disease [55], CX3CR1 on CD14- CD16- monocytes was associated with a lower risk of developing cerebral aneurysms [56] and was associated with a higher risk of chronic pancreatitis [57].